Raul F Valenzuela Perez, MD
Department of Musculoskeletal Imaging, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Musculoskeletal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Development and validation of MRI sequences and standardization.
Education & Training
Degree-Granting Education
| 2005 | University of Chile Business School, Santiago, CL, Process Management and Health Administration, Certificate |
| 2003 | University of Chile Business School, Santiago, CL, Business and Health Administration, Certificate |
| 1993 | Universidad De Chile, Santiago, CL, MD |
Postgraduate Training
| 2018-2019 | Clinical Fellowship, Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2017-2018 | Clinical Fellowship, Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2017 | Clinical Fellowship, Neuro Oncology and Functional Neuroradiology, UT Health Science Center, Houston, Texas |
| 2015-2016 | Clinical Fellowship, Neuroradiology ACGME accredited Fellowship, UT Health Science Center, Houston, Texas |
| 1997-1998 | Post-doctoral, MRI Oncology, The University of Texas MD Cancer Center, Houston, Texas |
| 1993-1996 | Clinical Residency, Radiology, Pontificia Universidad Catolica de Chile, Santiago |
Board Certifications
| 2020 | Chilean Radiology |
| 2019 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
MSK MRI Director, Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Other Appointments/Responsibilities
Member, Leiomyosarcoma Imaging Workgroup, Houston, TX, 2024 - Present
MSK Radiology Representative; Medical Sarcoma, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
MSK Radiology Representative; Myeloma Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
MSK Radiology Representative; Spine Stereotactic Radiosurgery Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
MSK Radiology Representative; The Sarcoma Surgical Oncology Research Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
MSK Radiology Representative; Head and Neck Cancer Review, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
MSK Radiology Representative; MRI Imaging Review, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - Present
Institutional Committee Activities
Member, Musculoskeletal Executive Committee, 2024 - Present
Member, Contrast Committee (iodinated+gadolinium), 2023 - Present
Member, Post-engagement Committee for Siemens and GE MRI Upgrade Deployment, 2023 - Present
Member, Surgical Oncology Sarcoma Surgical Care Conference Series, 2023 - Present
Member, Junior Faculty Committee, 2020 - Present
Honors & Awards
| Certificate of Merit, Radiological Society of North America | |
| Outstanding Clinician Award, Patient Care, UT MD Anderson Cancer Center |
Selected Publications
Peer-Reviewed Articles
- Valenzuela RF, Duran Sierra EJ, Canjirathinkal MA, Amini B, Hwang KP, Ma J, Torres KE, Stafford RJ, Wang WL, Benjamin RS, Bishop AJ, Madewell JE, Murphy WA, Costelloe CM. Novel use and value of contrast-enhanced susceptibility-weighted imaging morphologic and radiomic features in predicting extremity soft tissue undifferentiated pleomorphic sarcoma treatment response. JCO Clin Cancer Inform 9(None):e2400042, 2025. e-Pub 2025. PMID: 39841956.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy WA Jr, Costelloe CM. Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response. Sci Rep 14(1):21681, 2024. e-Pub 2024. PMID: 39289469.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy Jr WA, Costelloe CM. Radiomics by quantitative diffusion-weighted MRI for predicting response in patients with extremity soft-tissue undifferentiated pleomorphic sarcoma. J Radiol Oncol 8(2):064-071, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal MA, Amini B, Ma J, Hwang KP, Stafford RJ, Torres KE, Zarzour MA, Livingston JA, Madewell JE, Murphy WA, Costelloe CM. Contrast-enhanced susceptibility weighted imaging (CE-SWI) for the characterization of musculoskeletal oncologic pathology: a pictorial essay on the initial five-year experience at a cancer institution. J Radiol Oncl 8(None):030-045, 2024. e-Pub 2024. PMID: None.
- Griffith JF, Yip SWY, van der Heijden RA, Valenzuela RF, Yeung DKW. Perfusion imaging of the musculoskeletal system. Magn Reson Imaging Clin N Am 32(1):181-206, 2024. e-Pub 2024. PMID: None.
- Sierra ED, Valenzuela R, Canjirathinkal MA, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Cancer radiomic and perfusion imaging automated framework: validation on musculoskeletal tumors. JCO Clin Cancer Inform 8:e2300118, 2024. e-Pub 2024. PMID: 38181324.
- Valenzuela RF, De-Camino M, Tavera A, Sánchez J, Valenzuela PV, Canjirathinkal M, Durán EDJ. Idiopathic intracranial hypertension: cranial magnetic resonance imaging findings correlation with direct venous sinus pressure measurements. Rev Chil Radiol 29(4):1-8, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Duran Sierra E, Canjirathinkal MA, Costelloe CM, Madewell JE, Murphy WA, Amini B. Early results in the novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: A pilot study in a specialized cancer institution. Tumor Discov 2(3):1-9, 2023. e-Pub 2023. PMID: None.
- Amini B, Chenglei L, Duran-Sierra E, Wang WL, Canjirathinkal MA, Moradi H, Green WN, Madewell JE, Costelloe CM, Murphy WA, Valenzuela RF. Role of apparent diffusion coefficient map-based first-and high-order radiomic features for the discrimination of sacral chordomas and chondrosarcomas with overlapping conventional imaging features. JCO Precis Oncol 7(7):e2300243, 2023. e-Pub 2023. PMID: 38127828.
- Valenzuela RF, Amini B, Duran-Sierra E, Canjirathinkal MA, Madewell JE, Costelloe CM, Murphy WA. Multiparametric MRI for the assessment of treatment effect and tumor recurrence in soft-tissue sarcoma of the extremities. J Radiol Oncl 7(3):058-065, 2023. e-Pub 2023. PMID: None.
- Amini B, Valenzuela RF, Bird JE, Haygood TM. Osteoid Tumors of Bone. Semin Ultrasound CT MR 42(2):134-149, 2021. e-Pub 2021. PMID: 33814101.
- Valenzuela RF, Kundra V, Madewell JE, Costelloe CM. Advanced imaging in Musculoskeletal oncology: Moving away from RECIST and embracing advanced bone and soft tissue tumor imaging (ABASTI) - Part I - tumor response criteria and established functional imaging techniques. Semin Ultrasound CT MR 42(2):201-214, 2021. e-Pub 2021. PMID: 33814106.
- Valenzuela RF, Madewell JE, Kundra V, Costelloe CM. Advanced Imaging in Musculoskeletal Oncology: Moving away from RECIST and embracing advanced bone and soft tissue tumor imaging (ABASTI)—Part II—novel functional imaging techniques. Semin Ultrasound CT MR 42(2):215-227, 2021. e-Pub 2021. PMID: 33814107.
- Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, Bhosale P. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY) 45(11):3662-3680, 2020. e-Pub 2020. PMID: 32417933.
- Mujtaba B, Call C, Rowland F, Spear RP, Amini B, Valenzuela R, Nassar S. Desmoid fibromatosis following surgical resection of spinal meningioma. Radiol Case Rep 15(6):697-701, 2020. e-Pub 2020. PMID: 32280401.
- Hwang K, Valenzuela RF, Amini B, Stafford R. 3D acquisition and reconstruction protocol for lumbar spine imaging. Med Phys 45:2779, 2018. e-Pub 2018. PMID: None.
- Valenzuela RF, Ocasio L, Meenakshi B, Guangrong B, Rao LM, Tandon N, Esquenazi Y, Zhu JJ, Riascos-Castaneda R. Pathology confirmed radiographic diagnosis of true progression and pseudo-progression made by advanced brain tumor imaging. Neuro-Oncology 19(6):vi147, 2017. e-Pub 2017. PMID: None.
- Arevalo OJ, Valenzuela RF, Esquenazi Y, Rao M, Tran B, Zhu J, Bhattacharjee M, Doyle N, Riascos RF. The 2016 World Health Organization classification of tumors of the central nervous system: A practical approach for gliomas, Part 2. Isocitrate dehydrogenase status - imaging correlation. Neurographics 7(5):344-349, 2017. e-Pub 2017. PMID: None.
- Arevalo OJ, Valenzuela RF, Esquenazi Y, Rao M, Tran B, Zhu J, Bhattacharjee M, Fonseca P, Doyle N, Riascos RF. The 2016 World Health Organization classification of tumors of the central nervous system: A practical approach for gliomas, Part 1. Basic tumor genetics. Neurographics 7(5):334-343, 2017. e-Pub 2017. PMID: None.
- Valenzuela RF, Arevalo O, Tavera A, Riascos R, Bonfante E, Patel R. Gadolinium deposits in the central nervous system. Rev Chil Rad 23(2):59-65, 2017. e-Pub 2017. PMID: None.
- Wangaryattawanich P, Chavali LS, Shah KB, Gogia B, Valenzuela RF, DeMonte F, Kumar AJ, Hayman LA. Reformatierte kontrastverstärkte MRT-Aufnahmen zur präoperativen Beurteilung der Brückenvenen an der Schädelbasis. Neuroradiologie. Neuroradiologie Scan 06(2):157-174, 2016. e-Pub 2016. PMID: None.
- Wangaryattawanich P, Chavali LS, Shah KB, Gogia B, Valenzuela RF, DeMonte F, Kumar AJ, Hayman LA. Contrast-enhanced reformatted MR images for preoperative assessment of the bridging veins of the skull base. Radiographics 36(1):244-57, 2016. e-Pub 2016. PMID: 26761539.
- Valenzuela RF, Ginsberg L, Shatzkes D, Michel M, Loevner L, Hanna E, Tavera A, Riascos R. Dural metastases: a form of recurrence in uncommon sino nasal malignancies. Rev Chil Radiol 22(4):164-170, 2016. e-Pub 2016. PMID: None.
- Valenzuela RF. Whole body bone marrow screening using MRI and T1-WI. Rev Chil Radiol 10(1), 2004. e-Pub 2004. PMID: None.
- Valenzuela RF. Skull base: Anatomy and tumor spread pathways. Rev Chil Radiol 8(4):170-176, 2002. e-Pub 2002. PMID: None.
- Kim EE, Valenzuela RF, Kumar AJ, Raney RB, Eftekari F. Imaging and clinical spectrum of rhabdomyosarcoma in children. None 24(5):257-62, 2000. e-Pub 2000. PMID: 11331151.
- Valenzuela RF, Kim EE, Seo JG Patel S, Yasko AW. A revisit of MRI analysis for synovial sarcoma. Clinical Imaging 24(4):231-235, 2000. e-Pub 2000. PMID: None.
- Valenzuela RF. Synovial sarcoma: primary and recurrent tumor MRI findings. Rev. Chil Radiol 4(1):4-8, 1998. e-Pub 1998. PMID: None.
- Valenzuela RF. Sinus and nasal tumoral spread pattern and imaging features. Rev Chil Radiol 4(2):38-45, 1998. e-Pub 1998. PMID: None.
- Valenzuela RF. Small bowel intussusception related to Peutz-Jeghers disease. None 2(1):43-44, 1996. e-Pub 1996. PMID: None.
- Valenzuela RF. Abdominal tumoral spread pathways summarized. Rev Chil Radiol 2(3):15-27, 1996. e-Pub 1996. PMID: None.
- Valenzuela RF. Computed tomography cholangiogram. Rev. Chil Radiol 2(2):18, 1996. e-Pub 1996. PMID: None.
- Valenzuela RF. Epidermoid cyst of the spleen. Rev. Chil Radiol 1:27-28, 1995. e-Pub 1995. PMID: None.
Other Articles
- Griffith, JF, Yip, SW, van der Heijden, RA, Valenzuela Perez, RF, Yeung, DK Perfusion Imaging of the Musculoskeletal System. Magnetic resonance imaging clinics of North America 32(1):181-206, 2024. PMID: 38007280.
Abstracts
- Valenzuela RF, Duran-Sierra D, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Multiparametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). ESR European Congress of Radiology 2024 Science and Educational Programme None(None):None, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Perfusion weighted imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2024 Science and Educational Programme None(None):None, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). ESR European Congress of Radiology 2024 Science and Educational Programme None(None):None, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. ESR European Congress of Radiology 2024 Science and Educational Programme None(None):None, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran Sierra E, Canjirathinkal M, Costelloe CM, Madewell JE, Murphy WA, Amini B. Role of contrast-enhanced susceptibility-weighted imaging (CE-SWI) for the assessment of response and progression in desmoid fibromatosis. 2024 American Roentgen Ray Society Annual Meeting, 2024. e-Pub 2024. PMID: None.
- Amini B, Duran-Sierra E, Madewell J, Murphy W, Costelloe C, Valenzuela RF. Advanced MRI can be used to determine percent necrosis in leiomyosarcoma. ESR European Congress of Radiology 2024 Science and Educational Programme None(None):None, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Perfusion weighted-imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Amini B, Duran-Sierra E, Canjirathinkal, Madewell JE, Costelloe CM, Murphy WA. Multi-parametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024. PMID: None.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024. PMID: None.
- Duran Sierra E, Valenzuela RF, Antony M, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Cancer radiomic and perfusion imaging (CARPI) automated framework: validation on musculoskeletal tumors in a specialized cancer center. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Amini B, Duran Sierra E, Antony M, Costelloe CM, Madewell JE, Murphy WA. Early results in novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: pilot study in a specialized cancer institution. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CM, Murphy WA. Apparent diffusion coefficient (ADC) high-order radiomic of baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Duran Sierra E, Valenzuela RF, Antony M, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Baseline and post-treatment advanced MRI of extremities soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Livingston JA, Cloutier JM, Conley AP, Gorlick R, Benjamin R, Posey K, Nassif EF, Zarzour M, Araujo DM, Ratan R, Ravi V, Somaiah N, Lin H, Leung CH, Lazar AJ, Lewis V, Lin P, Amini B, Valenzuela RF, Patel S, Wang WL. Chemotherapy and prognostic significance of extent of dedifferentiation in dedifferentiated parosteal osteosarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Amini B, Valenzuela RF, Duran Sierra E, Antony M, Murphy WA, Liu C, Green WN, Griggs M, Wang WL. Role of apparent diffusion coefficient (ADC) map-based first and high-order radiomic features in discriminating sacral chordomas and chondrosarcomas with overlapping conventional imaging features. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CM, Murphy WA. Role of perfusion weighted imaging with dynamic contrast enhanced (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CE, Murphy WA. Contrast-enhanced susceptibility imaging (CE-SWI) morphologic, first & high-order radiomic features value in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF. Advanced imaging of soft tissue tumors of extremities. Peruvian Society of Radiology Peru 2023 Meeting, 2023. e-Pub 2023. PMID: None.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Murphy M, Madewell J, Costelloe C, Amini B. Apparent diffusion coefficient (ADC) high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme None(None):None, 2023. e-Pub 2023. PMID: None.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy, Jr, WA, Amini B. Diffusion-Weighted Imaging First order Radiomic Features Differentiate Pelvic Chordomas and Chondrosarcomas. 46th Society of Skeletal Radiology 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Valenzuela, RF, Amini B, Canjirathinkal M, Duran-Sierra E, Murphy, Jr WA, Idrees H, Madewell JE, Costelloe C. Baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023. PMID: None.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Madewell JE, Murphy, Jr WA, Costelloe C, Amini B. Susceptibility imaging (SWI) morphologic patterns and high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme None(None):None, 2023. e-Pub 2023. PMID: None.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy, Jr, WA, Amini B. Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Amini B, Canjirathinkal MA, Idrees H, Madewell JE, Costelloe C, Murphy, Jr WA. Susceptibility-Weighted imaging (SWI) in benign and malignant tumors of the musculoskeletal system. ESR European Congress of Radiology 2023 Science and Educational Programme None(None):None, 2023. e-Pub 2023. PMID: None.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy, Jr, WA, Amini B. Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. 46th Society of Skeletal Radiology 2023 Annual Meeting, 2023. e-Pub 2023. PMID: None.
- Chenglei L, Valenzuela RF, Green W, Canjirathinkal M, Griggs M, W-L W, Murphy, Jr WA, Amini B, Madewell JE, Costelloe C. Apparent diffusion coefficient (ADC) first-order radiomic features differentiate pelvic chordomas and chondrosarcomas. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023. PMID: None.
- Valenzuela RF, Riascos R, Ocasio L, Ramirez M, Marcus D, Cano-Duran A. Idiopathic intracranial hypertension: cranial MRI findings in correlation with direct venous sinus pressure measurements. Annual meeting of the American Society of Head and Neck Radiology, 2017. e-Pub 2017. PMID: None.
- Valenzuela RF, Hayman A, Bhanu G, Lakshmi C, Kumar AJ, Riascos R. Primary brain tumors in language associated brodmann areas (LABA). Annual meeting of the American Society of Head and Neck Radiology, 2016. e-Pub 2016. PMID: None.
Book Chapters
- Costelloe C, Valenzuela RF, Chuang H, Madewell J. Imaging of Bone Metastases. In: Cancer Metastasis Through the Lymphovascular System: A Comprehensive Textbook. None. Springer, 295-308, 2022.
- Kerr K, Valenzuela RF, Westmark K, Esquenazi YL. Incidental findings in neurosurgery and their management. In: Incidental Diffuse Gliomas. None. Thieme, 2020.
Books (edited and written)
- Valenzuela RF. Technical Innovations Where body imaging is leading to?. Ed(s) None. None, 2011.
Selected Presentations & Talks
Local Presentations
- 2025. Radiomics Overview in Sarcoma. Conference. NF1 MPNST Research Meeting. Houston, Texas, US.
- 2025. ABASTI Radiomics. Conference. Advanced Bone and Soft-Tissue Tumor (ABASTI) Imaging Research: Into in the Future. Houston, Texas, US.
- 2025. Extension study following successful pilot evaluating contrast-enhanced susceptibility-weighted imaging-based modified Choi (m-Choi) index, volumetrics, first-order and high-order radiomics for assessing desmoid fibromatosis response. Conference. Advanced Bone and Soft-Tissue Tumor (ABASTI) Imaging Research: Into in the Future. Houston, Texas, US.
- 2024. Radiomics Overview in Sarcoma. Conference. NF1 Research Meeting. Houston, TX, US.
- 2024. ABASTI and Radiomics. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2023. Advanced Imaging for Sarcoma. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2023. ABASTI concepts in soft-tissue sarcoma of the extremities. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2024. Advanced tumor protocoling. Invited. Penn Medicine University City, Department of Radiology. Philadelphia, Pennsylvania, US.
- 2024. PANEL: DTRF Multi-Disciplinary Mock Tumor Board. Invited. 2024 Desmoid Tumor Research Foundation. Houston, Texas, US.
- 2024. Oral Presentation, Contrast-enhanced susceptibility imaging applications in MSK oncology. Invited. 2024 American Roentgen Ray Society, Virtual Symposium, Advances in Neurological and Musculoskeletal Tumor Imaging. Houston, TX, US.
- 2024. Exhibit, Role of contrast-enhanced susceptibility-weighted imaging (CE-SWI) for the assessment of response and progression in desmoid fibromatosis. Conference. 2024 American Roentgen Ray Society Annual Meeting. Boston, MA, US.
- 2024. Oral Presentation, ABASTI and Radiomics. Invited. ECOG-ACRIN Spring 2024 Group Meeting. Baltimore, MD, US.
- 2024. Oral Presentation, Novel use of Contrast-Enhanced Susceptibility Imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. 47th Society of Skeletal Radiology 2024 Annual Meeting. San Juan, PR, US.
- 2024. Exhibit, Multiparametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. 47th Society of Skeletal Radiology 2024 Annual Meeting. San Juan, PR, US.
- 2024. Exhibit, Perfusion weighted-imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma (UPS). Conference. 47th Society of Skeletal Radiology 2024 Annual Meeting. San Juan, PR, US.
- 2024. Exhibit, Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. Conference. 47th Society of Skeletal Radiology 2024 Annual Meeting. San Juan, PR, US.
- 2023. Oral Presentation, Diffusion-Weighted Imaging First order Radiomic Features Differentiate Pelvic Chordomas and Chondrosarcomas. Conference. 46th Society of Skeletal Radiology Annual Meeting. Savannah, GA, US.
- 2023. Exhibit, Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. Conference. 46th Society of Skeletal Radiology Annual Meeting. Savannah, GA, US.
- 2022. Exhibit, MKEE-30HC: Susceptibility-Weighted Imaging (SWI) emerging role in Musculoskeletal (MSK) Oncology. Conference. 108th Scientific Assembly and Annual Meeting of Radiological Society of North America. Chicago, IL, US.
- 2022. Exhibit, Baseline, post-treatment and surveillance advanced magnetic resonance imaging of soft-tissue sarcomas. Conference. 108th Scientific Assembly and Annual Meeting of Radiological Society of North America. Chicago, IL, US.
- 2022. Keynote Presentation, Advanced imaging features of primary and recurrent soft-tissue sarcoma. Invited. 108th Scientific Assembly and Annual Meeting of Radiological Society of North America. Chicago, IL, US.
- 2018. 3D acquisition and reconstruction protocol for lumbar spine imaging. Conference. 60th Annual Meeting and Exhibition American Association of Physicists in Medicine. Nashville, TN, US.
- 2017. Pathology confirmed radiographic diagnosis of true progression and pseudo-progression made by advanced brain tumor imaging. Conference. The 22nd Annual Scientific Meeting of the Society for Neuro-Oncology. San Francisco, CA, US.
- 2017. Idiopathic intracranial hypertension: cranial MRI findings in correlation with direct venous sinus pressure measurements. Conference. American Society of Head and Neck Radiology, US.
- 2016. Dural metastases: a form of recurrence in uncommon sino nasal malignancies. Conference. American Society of Head and Neck Radiology. Washington, DC, US.
- 2016. Primary brain tumors in language associated broadmann areas (LABA). Conference. American Society of Head and Neck Radiology. Washington, DC, US.
International Presentations
- 2024. MD Anderson LMS Chapter Ambassador Imaging and Radiomics Experts. Panelist. National Leiomyosarcoma Foundation - SPAN International LMS Research Roundtable. Toronto, CA.
- 2024. Exhibit, Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Multiparametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Perfusion weighted imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Advanced MRI can be used to determine percent necrosis in leiomyosarcoma. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Chemotherapy and prognostic significance of extent of dedifferentiation in dedifferentiated parosteal osteosarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Apparent diffusion coefficient (ADC) high-order radiomic of baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Baseline and post-treatment advanced MRI of extremities soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Cancer radiomic and perfusion imaging (CARPI) automated framework: validation on musculoskeletal tumors in a specialized cancer center. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Contrast-enhanced susceptibility imaging (CE-SWI) morphologic, first & high-order radiomic features value in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Early results in novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: pilot study in a specialized cancer institution. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Role of apparent diffusion coefficient (ADC) map-based first and high-order radiomic features in discriminating sacral chordomas and chondrosarcomas with overlapping conventional imaging features. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Role of perfusion weighted imaging with dynamic contrast enhanced (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Advanced imaging of soft tissue tumors of extremities. Invited. Peruvian Society of Radiology, PE.
- 2023. Oral Presentation, Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Oral Presentation, Apparent diffusion coefficient (ADC) first-order radiomic features differentiate pelvic chordomas and chondrosarcomas. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Susceptibility imaging (SWI) morphologic patterns and high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma (C-19060). Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Oral Presentation, Baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Susceptibility-Weighted imaging (SWI) in benign and malignant tumors of the musculoskeletal system (C-19005). Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Apparent diffusion coefficient (ADC) high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma (C-20144). Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2022. Presentation, Diffusion-Weighted imaging for differentiation of sacral chordoma and chondrosarcoma. Conference. Connective Tissue Oncology Society. Vancouver, CA.
- 2020. MSK onco avanzado - soft tissue and bone tumors. Invited. VII Curso Internacional de Radiologia Oncologica. Lima, PE.
- 2020. ABASTI. Invited. VII Curso Internacional de Radiologia Oncologica. Lima, PE.
- 2020. Intrahepatic cholangiocarcinoma and MRI. Invited. VII Curso Internacional de Radiologia Oncologica. Lima, PE.
- 2020. Diserminacion perineural - PNS perineural spread in head and neck tumors. Invited. VII Curso Internacional de Radiologia Oncologica. Lima, PE.
- 2020. DWI in MSK onco. Invited. VII Curso Internacional de Radiologia Oncologica. Lima, PE.
- 2018. Keynote: Broadman and venous anatomy of brain tumors. Invited. XXIV 2024 CICOM. Guadalajara, MX.
- 2018. Keynote: Genetic and brain tumor imaging bio markers. Invited. XXIV 2024 CICOM. Guadalajara, MX.
- 2018. Keynote: Update epilepsy imaging broadman and venous anatomy of brain tumors. Conference. XXIV 2024 CICOM. Guadalajara, MX.
- 2016. Keynote: Update epilepsy imaging. Invited. XXIV 2024 CICOM. Guadalajara, MX.
Grant & Contract Support
| Title: | Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
Patient Reviews
CV information above last modified February 21, 2025